相似文献
1
Risk factors for multiple sclerosis in the context of Epstein-Barr virus infection.
Front Immunol. 2023 Jul 24;14:1212676. doi: 10.3389/fimmu.2023.1212676. eCollection 2023.
2
Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies.
J Neurol Sci. 2016 Feb 15;361:213-9. doi: 10.1016/j.jns.2016.01.013. Epub 2016 Jan 6.
3
MINI-review of Epstein-Barr virus involvement in multiple sclerosis etiology and pathogenesis.
J Neuroimmunol. 2022 Oct 15;371:577935. doi: 10.1016/j.jneuroim.2022.577935. Epub 2022 Jul 28.
4
Systematic review and meta-analysis of the association between Epstein-Barr virus, multiple sclerosis and other risk factors.
Mult Scler. 2020 Oct;26(11):1281-1297. doi: 10.1177/1352458520907901. Epub 2020 Mar 23.
5
Lifestyle and Environmental Factors in Multiple Sclerosis.
Cold Spring Harb Perspect Med. 2019 Apr 1;9(4):a028944. doi: 10.1101/cshperspect.a028944.
6
Altered Immune Response to the Epstein-Barr Virus as a Prerequisite for Multiple Sclerosis.
Cells. 2022 Sep 4;11(17):2757. doi: 10.3390/cells11172757.
7
Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
Med Hypotheses. 2016 Jun;91:109-113. doi: 10.1016/j.mehy.2016.04.025. Epub 2016 Apr 16.
8
Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
J Virol. 2019 Nov 26;93(24). doi: 10.1128/JVI.00980-19. Print 2019 Dec 15.
9
Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosis.
Mult Scler. 2024 Mar;30(3):308-315. doi: 10.1177/13524585231224685. Epub 2024 Feb 9.
10
Epstein-Barr virus and multiple sclerosis.
Nat Rev Microbiol. 2023 Jan;21(1):51-64. doi: 10.1038/s41579-022-00770-5. Epub 2022 Aug 5.
引用本文的文献
1
A narrative review of genetic and environmental factors and risk for multiple sclerosis. The design of the Italian multicentric PEDIGREE study.
Neurol Sci. 2025 Aug 15. doi: 10.1007/s10072-025-08385-3.
2
Early-life and adult body mass index in relation to MS disability progression.
J Neurol. 2025 Aug 12;272(9):571. doi: 10.1007/s00415-025-13319-2.
3
Exploring the Link Between IL-6 rs1800795 G > C SNP and the Severity of Epstein-Barr Virus-Associated Multiple Sclerosis: Potential Impact on Cognitive Impairment.
Mol Neurobiol. 2025 Jul 15. doi: 10.1007/s12035-025-05211-x.
4
An Updated and Comprehensive Review Exploring the Gut-Brain Axis in Neurodegenerative Disorders and Neurotraumas: Implications for Therapeutic Strategies.
Brain Sci. 2025 Jun 18;15(6):654. doi: 10.3390/brainsci15060654.
5
HERV Dysregulation in a Case of Myalgic Encephalomyelitis and Multiple Sclerosis Responsive to Rituximab.
Int J Mol Sci. 2025 May 20;26(10):4885. doi: 10.3390/ijms26104885.
6
Embodiment of structural racism and multiple sclerosis risk and outcomes in the USA.
Nat Rev Neurol. 2025 May 27. doi: 10.1038/s41582-025-01096-5.
7
Mapping the complexity of multiple sclerosis: a novel perspective on genetic, environmental, and neurobiological insights.
Mol Biol Rep. 2025 May 22;52(1):484. doi: 10.1007/s11033-025-10572-6.
8
Advancements in multiple sclerosis.
Intern Med J. 2025 Jun;55(6):895-904. doi: 10.1111/imj.70023. Epub 2025 Apr 2.
9
Public interest and engagement in care for brain health in Slovenia: the role of education.
Front Public Health. 2025 Mar 12;13:1490846. doi: 10.3389/fpubh.2025.1490846. eCollection 2025.
10
The Canadian collaborative project on genetic susceptibility to multiple sclerosis cohort population structure and disease etiology.
Front Neurol. 2025 Mar 5;16:1509371. doi: 10.3389/fneur.2025.1509371. eCollection 2025.
本文引用的文献
1
Risk HLA Variants Affect the T-Cell Repertoire in Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm. 2023 Feb 15;10(3). doi: 10.1212/NXI.0000000000200093. Print 2023 May.
2
Insufficient sleep during adolescence and risk of multiple sclerosis: results from a Swedish case-control study.
J Neurol Neurosurg Psychiatry. 2023 May;94(5):331-336. doi: 10.1136/jnnp-2022-330123. Epub 2023 Jan 23.
3
Association between exposure to combustion-related air pollution and multiple sclerosis risk.
Int J Epidemiol. 2023 Jun 6;52(3):703-714. doi: 10.1093/ije/dyac234.
4
Urgency and necessity of Epstein-Barr virus prophylactic vaccines.
NPJ Vaccines. 2022 Dec 9;7(1):159. doi: 10.1038/s41541-022-00587-6.
5
Autoimmunity as a sequela to obesity and systemic inflammation.
Front Physiol. 2022 Nov 21;13:887702. doi: 10.3389/fphys.2022.887702. eCollection 2022.
6
Comprehensive Investigations Relationship Between Viral Infections and Multiple Sclerosis Pathogenesis.
Curr Microbiol. 2022 Dec 2;80(1):15. doi: 10.1007/s00284-022-03112-z.
7
Siblings reduce multiple sclerosis risk by preventing delayed primary Epstein-Barr virus infection.
Brain. 2023 May 2;146(5):1993-2002. doi: 10.1093/brain/awac401.
8
Epstein-Barr virus and multiple sclerosis.
Nat Rev Microbiol. 2023 Jan;21(1):51-64. doi: 10.1038/s41579-022-00770-5. Epub 2022 Aug 5.
9
Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications.
Brain Commun. 2022 Jun 30;4(4):fcac171. doi: 10.1093/braincomms/fcac171. eCollection 2022.
10
Fatty acids role in multiple sclerosis as "metabokines".
J Neuroinflammation. 2022 Jun 17;19(1):157. doi: 10.1186/s12974-022-02502-1.
Zotero 插件